(FTV) Fortive - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US34959J1088
FTV: Software, Instruments, Solutions, Technologies, Services, Products
Fortive Corporation (NYSE: FTV) is a diversified industrial conglomerate that designs, manufactures, and delivers a wide range of professional and engineered products, software, and services globally. Headquartered in Everett, Washington, Fortive operates through three distinct segments, each catering to different industries and customer needs.
The Intelligent Operating Solutions segment is Fortives technology-driven arm, offering advanced tools and software that help industries optimize their operations. This includes electrical test and measurement devices, facility lifecycle management software, and connected worker safety solutions. Under this segment, Fortive markets its offerings through well-known brands like Accruent, Fluke, and Gordian, serving industries such as manufacturing, healthcare, utilities, and telecommunications.
The Precision Technologies segment focuses on delivering high-precision measurement and sensing solutions. This division serves a broad range of industries, including automotive, aerospace, energy, and semiconductor manufacturing. Brands like Tektronix, Keithley, and Qualitrol are part of this segment, providing critical tools for industries where accuracy and reliability are paramount.
The Advanced Healthcare Solutions segment is tailored to the medical industry, offering sterilization equipment, radiation monitoring, and clinical software solutions. This segment includes brands like Sterrad and Landauer, addressing the specialized needs of healthcare providers and life sciences companies.
From a financial perspective, Fortive Corporation has a market capitalization of approximately $26.985 billion USD, with a price-to-earnings (P/E) ratio of 33.51 and a price-to-sales (P/S) ratio of 4.47. These metrics indicate a company that is well-established and operates in sectors with stable demand, making it a potential candidate for investors seeking exposure to industrial and healthcare technologies.
Additional Sources for FTV Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
FTV Stock Overview
Market Cap in USD | 25,450m |
Sector | Technology |
Industry | Scientific & Technical Instruments |
GiC Sub-Industry | Industrial Machinery & Supplies & Components |
IPO / Inception | 2016-07-01 |
FTV Stock Ratings
Growth 5y | 42.5% |
Fundamental | 49.7% |
Dividend | 51.4% |
Rel. Strength | -19 |
Analysts | 3.9/5 |
Fair Price Momentum | 69.09 USD |
Fair Price DCF | 66.44 USD |
FTV Dividends
Dividend Yield 12m | 0.43% |
Yield on Cost 5y | 0.68% |
Annual Growth 5y | 5.40% |
Payout Consistency | 98.5% |
FTV Growth Ratios
Growth Correlation 3m | -44.7% |
Growth Correlation 12m | 19.5% |
Growth Correlation 5y | 61.5% |
CAGR 5y | 9.64% |
CAGR/Max DD 5y | 0.30 |
Sharpe Ratio 12m | -0.35 |
Alpha | -23.28 |
Beta | 1.212 |
Volatility | 20.69% |
Current Volume | 1147.4k |
Average Volume 20d | 2083.9k |
As of April 03, 2025, the stock is trading at USD 74.29 with a total of 1,147,362 shares traded.
Over the past week, the price has changed by -1.20%, over one month by -5.96%, over three months by -0.06% and over the past year by -12.05%.
Partly, yes. Based on ValueRay Fundamental Analyses, Fortive (NYSE:FTV) is currently (April 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 49.66 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of FTV as of April 2025 is 69.09. This means that FTV is currently overvalued and has a potential downside of -7%.
Fortive has received a consensus analysts rating of 3.90. Therefor, it is recommend to buy FTV.
- Strong Buy: 6
- Buy: 7
- Hold: 8
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, FTV Fortive will be worth about 77.8 in April 2026. The stock is currently trading at 74.29. This means that the stock has a potential upside of +4.68%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 90.2 | 21.5% |
Analysts Target Price | 87.9 | 18.3% |
ValueRay Target Price | 77.8 | 4.7% |